Several signalling pathways contribute to the regulation of epithelial to mesenchymal transition (EMT), either during developmentally regulated processes or in cancer progression and metastasis. Induction of EMT in fully polarized mouse mammary epithelial cells (EpH4) by an inducible cfos estrogen receptor (FosER) oncoprotein involves loss of E-cadherin expression, nuclear translocation of b-catenin, and autocrine production of TGFb. Reporter assays demonstrate that both b-catenin/LEF-TCF-and TGFbSmad-dependent signalling activities are upregulated, probably coregulating mesenchymal-specific gene expression during EMT. Stable expression of E-cadherin in mesenchymal FosER cells decreased b-catenin activity and reduced cell proliferation. However, these cells still exhibited a defect in epithelial polarization and expressed E-cadherin/b-catenin complexes in the entire plasma membrane. On the other hand, inhibition of TGFb-Smad signalling in mesenchymal FosER cells induced flat, cobblestone-like clusters of cells, which relocalized bcatenin to the plasma membrane but still lacked detectable E-cadherin. Interestingly, inhibition of TGFb signalling in the E-cadherin-expressing mesenchymal FosER cells caused their reversion to a polarized epithelial phenotype, in which E-cadherin, b-catenin, and ZO-1 were localized at their correct lateral plasma membrane domains. These results demonstrate that loss of E-cadherin can contribute to increased LEF/TCF-b-catenin signalling, which in turn cooperates with autocrine TGFb signalling to maintain an undifferentiated mesenchymal phenotype.
Introduction
The transition of epithelial cells to a mesenchymal phenotype (EMT) involves a complex network of signalling events and is characterized by loss of epithelial markers such as junctional-and cell-cell adhesion proteins. EMT takes place during mesoderm formation (Viebahn, 1995) and emigration of neural crest cells from the neural tube in avian and mammalian embryos (Duband et al., 1995) . In adult organisms, EMT has been implicated in tumor formation and progression to metastatic carcinomas and is generally induced by abnormal and/or persistent activation of various signalling pathways (Birchmeier et al., 1996) . The role of different pathways in inducing EMT reversibly or irreversibly has been studied in several cell-culture models, showing that many signalling proteins were involved in both EMT and cell proliferation (Thiery, 2002) .
Genes involved in TGFb signalling have been viewed as tumor suppressors, since TGFb causes apoptosis and proliferation inhibition due to transcriptional upregulation of cell-cycle control genes, including p15INK4B (Seoane et al., 2001) , CDC25A (Iavarone and Massague, 1997) , and c-myc (Warner et al., 1999) . However, additional evidence has accumulated indicating that TGFb also promotes tumor progression, driving local invasion and metastasis (Massague et al., 2000; Derynck et al., 2001) . The majority of human tumors seem to retain partially functional TGFb signalling, which lacks its proliferation-inhibiting function due to cooperation with MAP kinase or other signalling pathways. These cells are prone to undergo EMT in response to TGFb and establish an autocrine TGFb-signalling loop, which stabilizes the undifferentiated mesenchymal phenotype (Lehmann et al., 2000; Gotzmann et al., 2002; Janda et al., 2002) . In agreement with this hypothesis, high TGFb expression levels correlate with advanced clinical tumor stages (Gold, 1999) .
Mature TGFb binds to TGFb type II receptor (TbRII), which phosphorylates and activates a TGFb type I receptor (TbRI), which in turn phosphorylates Smad2 and Smad3 proteins (Massague et al., 2000) . These proteins form heteromeric complexes with Smad4, translocate to the nucleus and regulate the expression of target genes in close association with a variety of transcriptional activators and repressors (Ten Dijke et al., 2002) .
b-Catenin is a component of E-cadherin-type adherens junctions in epithelial cells Gumbiner, 2000) . It also functions as a downstream effector of the wnt/wingless signalling cascade and interacts with transcription factors of the LEF/TCF family, regulating gene expression and cell-fate decisions during embryonic development (Peifer and Polakis, 2000) . Inappropriate activation of b-catenin signalling is a frequent event during tumor progression, occurring through loss of E-cadherin or mutations in various bcatenin-signalling components (Roose and Clevers, 1999; Bienz and Clevers, 2000) . Transgenic mice overexpressing normal or truncated b-catenin in various organs develop intestinal polyps, mammary adenocarcinomas, and hair tumors (Gat et al., 1998; Harada et al., 1999; Michaelson and Leder, 2001) .
Constitutive activation of a c-Fos/estrogen receptor fusion protein (FosER) induces EMT in fully polarized mammary epithelial cells (Reichmann et al., 1992) . This correlated with loss of E-cadherin, nuclear translocation of b-catenin and upregulation of LEF/b-catenin transcriptional activity . In the mesenchymal cells, expression of exogenous E-cadherin sequesters b-catenin, causing downregulation of LEF activity and reduction in cell proliferation (Stockinger et al., 2001) . This suggests that b-catenin/LEF signalling is important for both proliferation and EMT. In a similar EpH4-based cell line, TGFb signalling was found to induce EMT and proliferation in cooperation with oncogenic Ras or Ras mutants that selectively hyperactivate the MAP kinase pathway (Oft et al., 1996; Janda et al., 2002) . In this paper, we show that FosER activation causes autocrine TGFb signalling at late stages of EMT and provide evidence that the TGFb pathway cooperates with b-catenin/LEF signalling in coregulating transcription, thus maintaining a stable mesenchymal phenotype. Interference with b-catenin signalling via E-cadherin expression and suppression of TGFb signalling with low-molecular-weight TbR-kinase inhibitors induced a reversion of mesenchymal FosER cells to a polarized epithelial phenotype.
Results

Upregulation of TGFb signalling during FosER-induced EMT
Mouse mammary epithelial cells stably expressing a fusion protein of the transcription factor c-Fos and the hormone-binding domain of the estrogen receptor (FosER) form polarized epithelial cell sheets in the absence of estradiol, but undergo EMT in a synchronous manner upon activation of the FosER protein by estradiol .
To test whether EMT in FosER cells involves upregulation of TGFb signalling, we cultivated epithelial FosER cells in an estradiol-containing medium for 4 and 10 days, prepared mRNA from epithelial (untreated) and estradiol-treated cells and performed RT-PCR using primers specific for TGFb isoforms. All three TGFb isoforms, TGFb-1-3, were expressed in epithelial and dedifferentiated cells, TGFb-1 mRNA showing an about fourfold increase upon incubation with estradiol ( Figure 1a ). Control assays of the same mRNA samples showed constant amounts of actin mRNA and a gradual loss of E-cadherin mRNA, confirming the use of equal amounts of mRNA for amplification and demonstrating that the cells underwent EMT, respectively.
We then determined total TGFb-1 concentrations in culture supernatants of FosER cells before and after estradiol treatment by enzyme-linked immunosorbent assays (ELISA). While supernatants from epithelial FosER cells exhibited low amounts of secreted TGFb-1, the protein concentration increased 15-and 40-fold in supernatants from cells treated for 4 and 10 days with estradiol, respectively (Figure 1b) . To examine whether released TGFb-1 was able to activate TGFb-signalling pathways, untreated and estradiol-treated cells were analysed for cytoplasmic or nuclear expression of Smad2 or Smad3 by immunofluorescence microscopy, using an antibody against a common epitope of Smad2/ 3. Epithelial FosER cells revealed diffuse, mainly cytoplasmic Smad2/3 staining, whereas significant levels of Smad2/3 proteins were detected in the nuclei of mesenchymal cells treated with estradiol for 10 days (Figure 2a ), indicating nuclear translocation of Smad heterooligomers in response to TGFb signalling.
To test whether autocrine TGFb signalling also caused TGFb-dependent transcriptional activation, we performed reporter gene assays employing three different TGFb-responsive promoter elements activated by different Smad proteins. These were the 'distal element of goosecoid' (DE), activated by Smad2/4 in the presence of the transcription factor mixer (Germain et al., 2000) , the TGFb /Smad3/4-responsive region of the plasminogen activator inhibitor (PAI) promoter (Dennler et al., 1998) , and a synthetic, multimerized Smad3 CAGA-binding motif (Jonk et al., 1998) . In all cases, reporter activity was upregulated about threefold in mesenchymal versus epithelial FosER cells 
Inhibition of TGFb signalling alters the phenotype of mesenchymal FosER cells
To analyse whether autocrine TGFb signalling during EMT is required for maintenance of the mesenchymal phenotype, we made use of a small molecular weight compound (BIBU 3029), which selectively inhibited TGFbR-serine kinase (TbR) activity in vitro. This compound inhibited the biological responses to TGFb-1 in several different cellular models, such as models for EMT, cell spreading, cell-cycle inhibition and differentiation, while showing no activity on a large number of other serine and tyrosine kinases (J Park, unpublished data). To test this inhibitor for interference with TGFbmediated transcriptional activation, mesenchymal FosER cells were pretreated with 2 and 10 mM TbR inhibitor for 24 h, transfected with the TGFb-dependent PAI-reporter plasmid, and assayed for luciferase activity in lysates prepared from cells, which were further cultivated for 48 h in TbR-inhibitor containing medium. The TbR-inhibitor reduced TGFb-dependent luciferase activity in a concentration-dependent manner down to approximately 50 and 15% of the control levels measured in untreated mesenchymal FosER cells (Figure 3a) .
Treatment of mesenchymal FosER cells for 3-6 days with TbR inhibitor induced a morphological reversion to a more adhesive phenotype independent of the inhibitor concentrations used (Figure 3b ). This suggested that reduction of TGFb-dependent activity by about 50% was sufficient to induce the phenotypic changes and that further downregulation of this activity had no effect on the cellular phenotype observed by light microscopy. Instead of growing as single, elongated, spindle-shaped, and weakly adhesive cells, the inhibitortreated mesenchymal FosER cells established cell-cell contacts, spread out, and attached more strongly to the plastic dish, although their overall appearance did not resemble cells in epithelial cell sheets ( Figure 3b ). Immunofluorescence microscopy revealed that these morphological changes were accompanied by a loss of nuclear and cytoplasmic b-catenin giving rise to a clear peripheral localization of b-catenin in inhibitor-treated cells ( Figure 4a , lower panel). As the total b-catenin levels did not change upon inhibitor treatment, revealed by immunoblot analysis of total cell lysates (Figure 4b ), we concluded that nuclear/cytoplasmic b-catenin was redistributed to the plasma membrane rather than degraded. However, E-cadherin was still not detectable, suggesting that membrane localization of b-catenin occurred independent of E-cadherin. Desmoplakin and ZO-1 (undetectable or purely cytoplasmic in untreated mesenchymal FosER cells, Figure 4a , upper panel) were found in distinct dots or short fibers at the cell periphery ( Figure 4a , lower panel), unlike their localization in epithelial cells in functional desmosomes or tight junctions, respectively. In summary, reduction of TGFb signalling in mesenchymal cells was not sufficient to induce complete reversion to a fully epithelial phenotype, most likely due to its inability to reinduce E-cadherin expression.
Cooperation of TGFb/Smad signalling and LEF/TCF in transcriptional activation
Since recruitment of b-catenin from nuclear and/or cytoplasmic pools to the plasma membrane by overexpression of E-cadherin was found to reduce b-catenin/ LEF/TCF-dependent transcription (Sadot et al., 1998; Orsulic et al., 1999; , we asked whether E-cadherin-independent plasma membrane translocation of b-catenin, mediated by the TbR inhibitor, would also reduce LEF/TCF signalling. Mesenchymal FosER cells were treated with 2 mM TbR inhibitor as described above (see Figure 3a) and transfected with To analyse whether inhibition of LEF/TCF signalling would in turn also reduce TGFb-mediated transcription, we tested both LEF/TCF-and TGFb-dependent reporter constructs in mesenchymal FosER cells, which stably express ectopic E-cadherin. Previous studies have shown that transient or stable expression of E-cadherin in these and other cell types strongly reduced LEF/TCF signalling Stockinger et al., 2001) . As measured by Topflash reporter assays, two different Ecadherin-expressing mesenchymal FosER cell clones exhibited only 15% of the b-catenin/LEF/TCF activity seen in control mesenchymal FosER cells lacking Ecadherin (Figure 5b ). Most interestingly, the E-cadherin-expressing mesenchymal cells also exhibited a strong reduction in TGFb-mediated transcriptional activity (Figure 5c ), demonstrating that inhibition of one signalling pathway adversely affected the other. The lower TGFb-mediated transcriptional activity in Ecadherin-expressing cell clones versus mesenchymal cells was further reduced by about 50% upon addition of 2 mM TbR inhibitor. Thus, E-cadherin-expressing mesenchymal cell clones still exhibited a significant level of TGFb-dependent transcriptional activity.
To further explore the interdependence of LEF/TCFand Smad-mediated signalling pathways, we ectopically expressed LEF-1 or the TGFb effector proteins Smad 2-4 in mesenchymal cells and measured changes in transcriptional activities of LEF/TCF-and TGFbdependent reporter constructs. While individual Smads activated transcription of TGFb-dependent reporter genes to different extents, also ectopic LEF-1 was able to activate transcription of TGFb-dependent reporter genes, consistent with a direct link of LEF-1 and TGFb pathways ( Figure 6, right panel) . Likewise, LEF-1-dependent reporter activity was not only upregulated by ectopic LEF-1 but also by ectopic Smad3 and Smad4 proteins ( Figure 6, left panel) . In contrast, Smad 2 was almost inactive on LEF/TCF reporters, suggesting that Smad3/4 heteromeric complexes are mainly responsible for the cooperation with LEF/TCF transcription factor. 
In summary, these data demonstrated a clear interdependence of LEF/TCF and TGFb signalling in mesenchymal FosER cells.
Expression of E-cadherin causes the establishment of an epitheloid phenotype
Although the TbR inhibitor caused mesenchymal FosER cells to lose their spindle-shaped morphology and gain a more adhesive, flattened phenotype, the cells did not revert to an epithelial morphology, most likely because they did not re-express E-cadherin and thus failed to form stable cell-cell contacts (see Figures 3, and  4) . Since ectopic E-cadherin reduced both LEF/TCFand TGFb-signalling activities in respective reporter assays (Figure 5b and c), we tested how exogenous Ecadherin expression would affect the fibroblastoid phenotype of mesenchymal FosER cells. Confocal immunofluorescence microscopy revealed that both Ecadherin-expressing clones formed epithelial-like cell sheets, in which E-cadherin was almost exclusively localized at the plasma membrane, recruiting endogenous b-catenin to the membrane region ( Figure 7 , upper panel). However, vertical optical sections showed that E-cadherin and b-catenin were distributed over the entire plasma membrane (Figure 7 , lower panels). Thus, E-cadherin re-expression was not sufficient to cause a polarized epithelial phenotype, a notion supported by the absence of fully assembled tight junctions as indicated by the rather diffuse and cytoplasmic localization of the tight junction marker protein ZO-1.
Inhibition of TGFb signalling in E-cadherin-expressing mesenchymal FosER cells restores a polarized epithelial phenotype
The above data show that neither E-cadherin expression nor inhibition of TGFb signalling alone caused a complete reversion to a differentiated epithelial phenotype. Furthermore, the E-cadherin-expressing clones still exhibited significant TGFb-mediated activity, which could be further reduced by TbR inhibitor treatment (see Figure 5c ). We therefore treated E-cadherinexpressing clones of mesenchymal FosER cells with TbR inhibitors for 6 days and examined their morphology and marker expression by phase-contrast and confocal immunofluorescence microscopy. These cells formed typical cobble-stone-like epithelial sheets, which expressed both E-cadherin and b-catenin in a strictly lateral manner, a typical feature of polarized epithelial cells (Figure 8a and b) . A high proportion of these cells also formed tight junctions as indicated by the peripheral localization of ZO-1 (Figure 8b ). This junction formation was dependent on the duration of inhibitor treatment, 40-50% of the cells showing high ZO-1 expression levels at the peripheral tight-junction belt after 6 days. On the other hand, treatment of Ecadherin-expressing mesenchymal FosER clones with TGFb induced disruption of cell contacts and a spindleshaped, fibroblastoid morphology (Figure 8a ). Thus, an increase of TGFb signalling in these cells overcame the partial reversion by exogenous E-cadherin. Altogether, our findings demonstrated that E-cadherin expression and TGFb signalling negatively or positively impinged on b-catenin/LEF/TCF activity, respectively, and might represent important functional determinants in regulating epithelial plasticity and dedifferentiation during EMT.
Discussion
A major aim of the etiopathology of cancer is to understand the signalling pathways that lead to dispersion, invasion, and metastasis of carcinoma cells, processes imitated by EMT cell-culture models in vitro (Thiery, 2002) . In this study, we examined the contribution of two signalling pathways, b-catenin/LEF/TCF and TGFb/Smads, to FosER-induced EMT. Both pathways are activated at late stages of EMT, suggesting a functional role in the maintenance of the dedifferentiated mesenchymal phenotype. Joint inhibition of LEF/TCF/b-catenin and TGFb signalling by ectopic expression of E-cadherin or treatment with low-molecular-weight TbR-kinase inhibitors, respectively, restored epithelial polarity in mesenchymal FosER cells. 
Contribution of TGFb signalling to EMT and cancer progression
While growth-inhibitory effects of TGFb may suppress tumor formation at early stages of malignancies, many tumor cells become refractive to growth inhibition by TGFb at later stages when TGFb promotes migration and invasiveness (Massague et al., 2000; Akhurst and Derynck, 2001 ). In various cell-culture model systems, TGFb promoted tumor progression and metastasis in cooperation with an activated Ha-ras/ MAP kinase pathway. The establishment of an autocrine TGFb loop was essential for the maintenance of a mesenchymal phenotype after EMT in these systems (Gotzmann et al., 2002; Janda et al., 2002) . The results described here demonstrate that EMT in FosER cells also involves a TGFb autocrine loop. However, while EMT in EpRas cells could be reverted by reagents interfering with TGFb signalling, including TbR-kinase inhibitor BIBU 3029 (Oft et al., 1996 (Oft et al., , 1998 ; H Beug, unpublished data), or with Ras inhibitors (Janda et al., 2002) , interference with TGFb signalling alone could not fully revert the epithelial phenotype of mesenchymal FosER cells. TGFbR-inhibitor treatment alone caused only partial translocation of b-catenin to the plasma membrane and induced weak cell-cell interactions, suggesting that other pathways may cooperate with TGFb to establish a mesenchymal gene expression program.
Effects of E-cadherin levels and b-catenin/LEF/TCF activity on the cellular phenotype and cancer progression LEF/TCF signalling is activated in many malignant tumors (Roose and Clevers, 1999; Bienz and Clevers, 2000; Polakis, 2000) and loss of E-cadherin expression might contribute to elevation of LEF/TCF activity by increasing the concentration of cytoplasmic b-catenin, making it available for the formation of nuclear transcription complexes . Accordingly, stable expression of ectopic E-cadherin in mesenchymal FosER cells strongly reduced LEF/TCF-dependent transcription, inhibited proliferation, and caused reversion of cells to an epitheloid phenotype (Stockinger et al., 2001 ). We could demonstrate that mesenchymal FosER clones stably expressing E-cadherin exhibited typical features of epithelial cells, such as strong intercellular contact formation, E-cadherin-mediated recruitment of b-catenin to the plasma membrane, and formation of desmosome-like structures. However, these cells were unable to form polarized epithelial cell sheets with restricted localization of E-cadherin-type junctions to the lateral plasma membrane and de novo formation of tight junctions.
In mesenchymal FosER cells cytoplasmic E-cadherin fragments, which are unable to mediate cell adhesion, can downregulate b-catenin/LEF/TCF activity and cell proliferation (Stockinger et al., 2001 ), but are not sufficient to induce an epithelial-like phenotype (A Eger, unpublished data). Nevertheless, recent studies have provided evidence that expression of a dominantnegative version of TCF4 in the colorectal cancer cellline DLD-1 was sufficient to induce establishment of a polarized epithelial phenotype, including formation of microvilli at the apical surface and redistribution of the tight-junction protein ZO-1 to the lateral plasma membrane (Naishiro et al., 2001) . One explanation why inhibition of b-catenin/LEF/TCF in FosER cells was not sufficient for complete epithelial reversion as seen in DLD-1 cells may be the complete loss of Ecadherin expression in mesenchymal FosER cells, while DLD1 cells still expressed considerable amounts of the protein Naishiro et al., 2001) . These data would argue for a role of both E-cadherinmediated cell adhesion and downregulation of bcatenin/LEF/TCF activity in epithelial polarization. Alternatively, dominant-negative TCF4 might also block b-catenin-independent mechanisms, such as the interaction of LEF/TCF proteins with Smad3/4 (Letamendia et al., 2001) , while binding of b-catenin by E-cadherin fragments inhibits predominantly b-catenin-dependent signalling functions.
In addition to experiments in DLD1 cells, a series of recent studies in tumor samples support a function of LEF/TCF-b-catenin in EMT and late-stage carcinogenesis (Barker and Clevers, 2001) . Colorectal carcinoma cells that have detached from the main tumor mass at the invasive front exhibit a mesenchymal phenotype, characterized by downregulation of E-cadherin and an upregulation of vimentin. In these cells, similar to the FosER tumor model , b-catenin was localized mainly in the cytoplasm and the nucleus, indicating active LEF/TCF/b-catenin signalling (Kirchner and Brabletz, 2000; Brabletz et al., 2001) . LEF/ TCF/b-catenin activity is thought to promote tumorigenesis, invasion and metastasis actively by upregulation of target genes, such as matrix metalloproteinases (Brabletz et al., 1999; Crawford et al., 1999) , CD44 (Wielenga et al., 1999) , fibronectin (Gradl et al., 1999) , uPar (Mann et al., 1999) , and the transcription factor slug, a key regulator of EMT (Vallin et al., 2001) .
Cooperation of LEF/TCF and Smad3/4 proteins
Previous observations indicated a cooperation of LEF/ TCF and TGFb pathways in the transcriptional regulation of a variety of target genes during embryonic development (Riese et al., 1997) . In the mammary gland, wnt-1 was found to cooperate with TGFb during the elongation and branching of epithelial tubules (Uyttendaele et al., 1998) . In addition, LEF1/TCF and bcatenin have been found to form a complex with Smad4 or Smad3 and this interaction directly and synergistically affected expression of the twin (Xtwn) gene during Spemann organizer formation in Xenopus (Nishita et al., 2000; Letamendia et al., 2001) . In mesenchymal FosER cells, we could detect a strong interdependence of both signalling pathways in different sets of reporter gene assays. Ectopic expression of Smad3 and Smad4 activated LEF/TCF-specific reporter genes and ectopic LEF-1 expression increased TGFb-specific reporter activity, albeit at a lower level. Furthermore, inhibition b-Catenin and TGFb signalling cooperate in carcinogenesis A Eger et al of one pathway significantly reduced reporter gene expression levels specific for the other. However, the results of our reporter gene assays differ from data reported in a previous study (Labbe et al., 2000) . While these authors reported that LEF-1 and Smad3 physically interacted and synergized to activate gene expression from the Xenopus homeobox twin gene promoter, they could not detect a cooperation of both proteins on LEF/TCF-specific reporters lacking Smad-binding elements (SBE), as seen in our study. However, also other studies reported a TGFb-activated and Smad3/Smad4-induced transcriptional response independent of an SBE (Yingling et al., 1996) . Thus, the different results might be due to cell-type-specific expression or activation of different sets of signalling proteins in FosER and HepG2 cells. In the renal proximal tubule cell-line HK-2, b-catenin has also been shown to associate with Smad3 and Smad4, following TGFb-1-induced disassembly of adherens junction (Tian and Phillips, 2002) . These interactions might be direct or mediated by bridging molecules, like the general coactivator p300/ CBP that interacts with both Smads (Attisano and Wrana, 2002) and b-catenin (Takemaru and Moon, 2000) , and might thus function as a docking platform to integrate LEF/TCF and Smad signalling. Importantly, our results not only showed cooperation of both pathways in the activation of synthetic reporter constructs but also in the determination of defined cellular phenotypes during EMT. Using loss-of-function approaches, we demonstrated that simultaneous inhibition of both pathways reverted mesenchymal FosER cells to a polarized epithelial phenotype, whereas inhibition of only a single pathway caused partial rescue of epithelial features. These observations directly demonstrate that both TGFb-and b-catenin/LEF pathways cooperate in epithelial dedifferentiation during EMT. We are currently performing DNAmicroarray analyses to identify target genes of these pathways that might function as crucial regulators of EMT, aiming at understanding the events during late-stage carcinogenesis, invasion, and metastasis.
Materials and methods
Cell culture
Mouse mammary epithelial cells constitutively expressing a cfos estrogen receptor fusion protein (FosER, Reichmann et al., 1992) and mesenchymal FosER cells ectopically expressing full-length E-cadherin (Mes-E-cad) were cultured as described previously Stockinger et al., 2001) . To inhibit TbR-kinase activities, cells were treated with lowmolecular-weight inhibitor BIBU 3029 at 2 or 10 mM. TGFb1 was purchased from R&D Systems, Minneapolis, USA and used at a concentration of 1 ng/ml.
RT-PCR
Cells were lysed in TRIzol reagent (Life technologies) and total RNA was prepared according to the manufacturer's instructions. PolyAÀmRNA were prepared from 125 mg total RNA using the mRNA Isolation Kit, and cDNA was synthesized using the first Strand cDNA Synthesis Kit (both Roche). cDNAs were used for PCR analysis using the Ready-To-Go PCR beads (Amersham-Pharmacia) and oligonucleotide primers specific for TGFb-1 (5 0 CTCCACCTG CAAGAC CATCG and 5 0 GGCAGGGTCCCAGACAGAAG), TGFb-2 (5 0 CCTGCTGT ACCTTCGTGCCGT and 5 0 AGCTGTT CGATCTTGGGCGT), TGFb-3 (5 0 ACTGGCGGA GCA CAATGAAC and 5 0 CCTGGGGGACGCAGCATGGC), Ecadherin (5 0 GAGCCTGA GTCCTGCAGTCC and 5 0 TGTA TTGCTGCTTGGCCTCA) and actin (5 0 ATCTGGCACCA CACCTTCTAC and 5 0 CAGCCAGGTCCAGACGCAGG). Quantification of TGFb RNA levels was performed with QuantiScan software from Biosoft.
Enzyme-linked immunosorbent assay
Epithelial cells, 4-day b-estradiol-treated cells, and mesenchymal cells were cultivated in serum-free RPMI medium for 48 h. Culture supernatants were analysed for TGFb-1 by ELISA, using the Quantikine TGFb-1 Immunoassay Kit (R&D Systems, Minneapolis, USA) as described previously (Gotzmann et al., 2002) .
Transient transfections and reporter gene assays
Transfection experiments were carried out in six-well plastic dishes (Nunc) using Lipofectamine 2000 (Life Technologies) according to the manufacturer's instructions. For determination of endogenous TGFb-dependent transcriptional activities, 3 mg of TGFb-or LEF/TCF-dependent reporter constructs (Topflash) (Korinek et al., 1997) , and 1 mg of b-galactosidase expression plasmid (pAD-CMV1:bgal, were used. For determination of transcriptional activities of ectopic LEF-1 and Smad proteins on LEF/TCF-dependent or TGFbdependent reporter constructs, 2 mg of murine LEF-1 , or murine Smad2, Smad3 or Smad4 expression constructs (gift from CS Hill, London, UK), and 1 mg of the bgalactosidase expression plasmid were transfected into cells. At 48 h after transfections, cells were lysed in 200 ml 0.25 M Tris/ HCl, pH 7.5, 0.5% Triton X-100, and soluble fractions were used for b-galactosidase and luciferase assays according to standard protocols.
Antibodies and immunofluorescence microscopy
The following immunoreagents were used: monoclonal antibodies against b-catenin, E-cadherin, Smad2/3 (Transduction Labs), ZO-1 (Chemicon Intl. Inc.), and desmoplakin I þ II (Progen Biotech). Secondary antibodies conjugated to Texas Red were purchased from Jackson ImmunoResearch Laboratories Inc. and antibodies coupled to Alexa Fluor 488 were obtained from Molecular Probes. For immunofluorescence microscopy, cells were fixed on plastic dishes with methanol/ acetone (1 : 1) for 5 min at À201C. Alternatively, cells were fixed with paraformaldehyde and processed for immunofluorescence analysis as described previously . Samples were mounted in Mowiol and viewed on a ZEISS Axiovert 100 M equipped with an LSM510 confocal microscope.
